Focus: OriGen Biomedical is a cell culture products company founded in 2005, specializing in biomedical research and manufacturing inputs for the biotechnology sector.
Profile data last refreshed 13h ago · AI intelligence enriched 1mo ago
Stable — net -4 jobs in 30d
0 added, 4 removed. Backfill posture.
OriGen is a defensible infrastructure play for professionals seeking stability in biotech, but limited transparency and modest hiring scale make it a secondary choice versus peers with clearer growth signals.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for OriGen Biomedical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from OriGen Biomedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles